Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 82


Effect of diaphragm and lubricant gel provision on human papillomavirus infection among women provided with condoms: a randomized controlled trial.

Sawaya GF, Chirenje MZ, Magure MT, Tuveson JL, Ma Y, Shiboski SC, Da Costa MM, Palefsky JM, Moscicki AB, Mutasa RM, Chipato T, Smith-McCune KK.

Obstet Gynecol. 2008 Nov;112(5):990-7. doi: 10.1097/AOG.0b013e318189a8a4. Erratum in: Obstet Gynecol. 2010 Sep;116(3):775.


Effect of Replens gel used with a diaphragm on tests for human papillomavirus and other lower genital tract infections.

Smith-McCune KK, Tuveson JL, Rubin MM, Da Costa MM, Darragh TM, Shiboski SC, Van Der Pol B, Moscicki AB, Palefsky JM, Sawaya GF.

J Low Genit Tract Dis. 2006 Oct;10(4):213-8.


Cervical human papillomavirus incidence and persistence in a cohort of HIV-negative women in Zimbabwe.

Fukuchi E, Sawaya GF, Chirenje M, Magure T, Tuveson J, Ma Y, Shiboski S, Da Costa M, Palefsky J, Moscicki AB, Makunike-Mutasa R, Chipato T, Smith-McCune KK.

Sex Transm Dis. 2009 May;36(5):305-11. doi: 10.1097/OLQ.0b013e318194eb76.


Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial.

Padian NS, van der Straten A, Ramjee G, Chipato T, de Bruyn G, Blanchard K, Shiboski S, Montgomery ET, Fancher H, Cheng H, Rosenblum M, van der Laan M, Jewell N, McIntyre J; MIRA Team.

Lancet. 2007 Jul 21;370(9583):251-61.


The effectiveness of Carraguard, a vaginal microbicide, in protecting women against high-risk human papillomavirus infection.

Marais D, Gawarecki D, Allan B, Ahmed K, Altini L, Cassim N, Gopolang F, Hoffman M, Ramjee G, Williamson AL.

Antivir Ther. 2011;16(8):1219-26. doi: 10.3851/IMP1890.


The use of the diaphragm instead of condoms in a phase III diaphragm trial.

van der Straten A, Cheng H, Moore J, Kacanek D, Blanchard K, De Bruyn G, Ramjee G, Chipato T, Montgomery ET, Padian N; MIRA Team.

AIDS Behav. 2009 Jun;13(3):564-72. doi: 10.1007/s10461-008-9504-z. Epub 2008 Dec 16.


Prevalence of human papillomavirus types 6, 11, 16 and 18 in young Austrian women - baseline data of a phase III vaccine trial.

Six L, Leodolter S, Sings HL, Barr E, Haupt R, Joura EA.

Wien Klin Wochenschr. 2008;120(21-22):666-71. doi: 10.1007/s00508-008-1093-3.


Predictors of adherent use of diaphragms and microbicide gel in a four-arm, randomized pilot study among female sex workers in Madagascar.

Turner AN, Van Damme K, Jamieson DJ, Khan MR, Pettifor AE, Swezey TA, Bell AJ, Newman DR, Penman-Aguilar A, Raharinivo MS, Randrianasolo B, Ramiandrisoa FN, Behets FM; Mad STI Prevention Group.

Sex Transm Dis. 2009 Apr;36(4):249-57. doi: 10.1097/OLQ.0b013e3181901aec.


Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.

Palefsky JM, Holly EA, Ralston ML, Da Costa M, Greenblatt RM.

J Infect Dis. 2001 Feb 1;183(3):383-91. Epub 2000 Dec 29.


Barrier contraceptive use and HIV infection among high-risk women in Cameroon.

Zekeng L, Feldblum PJ, Oliver RM, Kaptue L.

AIDS. 1993 May;7(5):725-31.


Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States.

Hildesheim A, Schiffman M, Scott DR, Marti D, Kissner T, Sherman ME, Glass AG, Manos MM, Lorincz AT, Kurman RJ, Buckland J, Rush BB, Carrington M.

Cancer Epidemiol Biomarkers Prev. 1998 Nov;7(11):1035-41.


The diaphragm and lubricant gel for prevention of cervical sexually transmitted infections: results of a randomized controlled trial.

Ramjee G, van der Straten A, Chipato T, de Bruyn G, Blanchard K, Shiboski S, Cheng H, Montgomery E, Padian N; MIRA team.

PLoS One. 2008;3(10):e3488. doi: 10.1371/journal.pone.0003488. Epub 2008 Oct 22.


Incidence and duration of cervical human papillomavirus 6, 11, 16, and 18 infections in young women: an evaluation from multiple analytic perspectives.

Insinga RP, Dasbach EJ, Elbasha EH, Liaw KL, Barr E.

Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):709-15.


The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years.

Brown DR, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Koutsky LA, Tay EH, Garcia P, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Steben M, Bosch FX, Dillner J, Joura EA, Kurman RJ, Majewski S, Muñoz N, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan J, Lupinacci LC, Giacoletti KE, Sings HL, James M, Hesley TM, Barr E.

J Infect Dis. 2009 Apr 1;199(7):926-35. doi: 10.1086/597307.


Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.

Branca M, Garbuglia AR, Benedetto A, Cappiello T, Leoncini L, Migliore G, Agarossi A, Syrjänen K; DIANAIDS Collaborative Study Group.

Int J STD AIDS. 2003 Jun;14(6):417-25.


The effect of the vaginal diaphragm and lubricant gel on acquisition of HSV-2.

de Bruyn G, Shiboski S, van der Straten A, Blanchard K, Chipato T, Ramjee G, Montgomery E, Padian N; MIRA Team.

Sex Transm Infect. 2011 Jun;87(4):301-5. doi: 10.1136/sti.2010.047142. Epub 2011 Mar 29.


Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Canadian Women's HIV Study Group.

Hankins C, Coutlée F, Lapointe N, Simard P, Tran T, Samson J, Hum L.

CMAJ. 1999 Jan 26;160(2):185-91.


Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls: impact of infection with human immunodeficiency virus.

Moscicki AB, Ellenberg JH, Vermund SH, Holland CA, Darragh T, Crowley-Nowick PA, Levin L, Wilson CM.

Arch Pediatr Adolesc Med. 2000 Feb;154(2):127-34.


Atypical squamous cells of undetermined significance: human papillomavirus testing in adolescents.

Boardman LA, Stanko C, Weitzen S, Sung CJ.

Obstet Gynecol. 2005 Apr;105(4):741-6.


The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection.

Daling JR, Madeleine MM, McKnight B, Carter JJ, Wipf GC, Ashley R, Schwartz SM, Beckmann AM, Hagensee ME, Mandelson MT, Galloway DA.

Cancer Epidemiol Biomarkers Prev. 1996 Jul;5(7):541-8.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk